Finance

Beta
Lists
MEDPLUS:NSE
MedPlus Health Services Ltd
₹845,00
-0,69%
(-5,90) 1D
19 Jun., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MEDPLUS...
Open
₹850,90
High
₹854,95
Low
₹840,75
Mkt. cap
101,18 mjd
Avg. vol.
251,82 k
Volume
74,43 k
P/E ratio
46,10
52-wk high
₹1 022,20
52-wk low
₹732,00
EPS
₹18,33
No. of employees
25 k
Open
₹850,90
High
₹854,95
Low
₹840,75
Mkt. cap
101,18 mjd
Avg. vol.
251,82 k
Volume
74,43 k
P/E ratio
46,10
52-wk high
₹1 022,20
52-wk low
₹732,00
EPS
₹18,33
No. of employees
25 k
News stories
From sources across the web
About MedPlus Health Services Ltd
CEO-
Employees25 k
Founded2006
Headquarters-
SectorDrug
Last report
21 Mei 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹5,33 / ₹5,15
+3,50%beat
Revenue / Est. (INR)
18,64 mjd / 18,59 mjd
+0,28%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
15,43 mjd
16,79 mjd
18,06 mjd
18,64 mjd
Cost of goods sold
11,40 mjd
12,40 mjd
13,34 mjd
13,71 mjd
Cost of revenue
11,40 mjd
12,40 mjd
13,34 mjd
13,71 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,00 mjd
2,13 mjd
2,33 mjd
2,38 mjd
Operating expense
3,38 mjd
3,59 mjd
3,87 mjd
4,00 mjd
Total operating expenses
14,78 mjd
15,99 mjd
17,20 mjd
17,71 mjd
Operating income
651,12 m
802,85 m
858,75 m
932,27 m
Other non operating income
150,19 m
174,69 m
182,41 m
205,95 m
EBT including unusual items
527,66 m
689,35 m
732,87 m
803,42 m
EBT excluding unusual items
527,66 m
689,35 m
732,87 m
803,42 m
Income tax expense
104,23 m
134,33 m
154,99 m
163,69 m
Effective tax rate
19,75%
19,49%
21,15%
20,37%
Other operating expenses
717,27 m
769,09 m
811,78 m
861,50 m
Net income
423,58 m
555,01 m
578,07 m
639,83 m
Net profit margin
2,75%
3,30%
3,20%
3,43%
Earnings per share
3,53
4,62
4,81
5,33
Interest and investment income
-
-
-
-
Interest expense
-273,65 m
-288,19 m
-308,29 m
-334,80 m
Net interest expenses
-273,65 m
-288,19 m
-308,29 m
-334,80 m
Depreciation and amortization charges
656,18 m
685,62 m
727,41 m
759,47 m
EBITDA
843,93 m
994,36 m
1,04 mjd
1,13 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more